| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine and Research [S. Z., J. M. W., R. M. L., D. W.], Veterans Administration Medical Center, Northport, New York 11768 and Schools of Dental Medicine [N. S. R., L. M. G.] and Medicine [S. Z., B. L.], Health Science Center, State University of New York at Stony Brook, Stony Brook, New York 11794
Interactions between connective tissue substrates and proteinases localized to the surface of cancer cells are implicated in cancer invasion. In this report we have compared the enrichment of collagen and gelatin degrading activities and cysteine proteinase(s) in well-characterized (enzyme markers and electron microscopy) subcellular membrane fractions isolated from human small cell lung cancer lines (NCI-H69 and NCI-H82) and the RWP-1 pancreatic cancer line. With each cell line collagenolytic, gelatinolytic, and cysteine proteinase activities were enriched 5- to 128-fold in the plasma membrane fractions with differences noted between microvilli versus smooth membrane profiles. Incubation of tumor plasma membranes with methyl-3H-labeled collagen resulted in extensive degradation of the
, ß,
1, and
2 chains, suggesting the combined action of metalloproteinases. Treatment of tumor plasma membranes with the chaotropic agent, 2 M KCl, did not diminish membrane collagenor gelatin-degrading activity, but extensively leached out the cysteine proteinase, suggesting that the latter enzyme is not an integral membrane protein. Enzyme inhibitors specific for metalloproteinases and cysteine proteinase were used to corroborate enzymatic classification. In conclusion, we have demonstrated variations in the localization of proteinases in the plasma membrane domains of different human cancer cells.
1 Supported by Merit Review Research Funds from the Veterans Administration and USPHS Grant DE-03987 from the National Institute of Dental Research.
2 To whom requests for reprints should be addressed, at Veterans Administration Medical Center, Northport, NY 11768.
Received 1/31/86. Revised 7/22/86. Revised 11/18/86. Accepted 12/11/86.
This article has been cited by other articles:
![]() |
T. Armstrong, G. Packham, L. B. Murphy, A. C. Bateman, J. A. Conti, D. R. Fine, C. D. Johnson, R. C. Benyon, and J. P. Iredale Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma Clin. Cancer Res., November 1, 2004; 10(21): 7427 - 7437. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Steffensen, L. Hakkinen, and H. Larjava Proteolytic Events of Wound-Healing -- Coordinated Interactions Among Matrix Metalloproteinases (MMPs), Integrins, and Extracellular Matrix Molecules Critical Reviews in Oral Biology & Medicine, January 1, 2001; 12(5): 373 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Velasco, S. Cal, A. Merlos-Suarez, A. A. Ferrando, S. Alvarez, A. Nakano, J. Arribas, and C. Lopez-Otin Human MT6-Matrix Metalloproteinase: Identification, Progelatinase A Activation, and Expression in Brain Tumors Cancer Res., February 1, 2000; 60(4): 877 - 882. [Abstract] [Full Text] |
||||
![]() |
H. D. Foda, S. George, E. Rollo, M. Drews, C. Conner, J. Cao, R. A. Panettieri Jr., and S. Zucker Regulation of gelatinases in human airway smooth muscle cells: mechanism of progelatinase A activation Am J Physiol Lung Cell Mol Physiol, July 1, 1999; 277(1): L174 - L182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Olson, M. Toth, D. C. Gervasi, Y. Sado, Y. Ninomiya, and R. Fridman High Affinity Binding of Latent Matrix Metalloproteinase-9 to the alpha 2(IV) Chain of Collagen IV J. Biol. Chem., April 24, 1998; 273(17): 10672 - 10681. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zucker, M. Drews, C. Conner, H. D. Foda, Y. A. DeClerck, K. E. Langley, W. F. Bahou, A. J. P. Docherty, and J. Cao Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) Binds to the Catalytic Domain of the Cell Surface Receptor, Membrane Type 1-Matrix Metalloproteinase 1 (MT1-MMP) J. Biol. Chem., January 9, 1998; 273(2): 1216 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Guo, S. Zucker, M. K. Gordon, B. P. Toole, and C. Biswas Stimulation of Matrix Metalloproteinase Production by Recombinant Extracellular Matrix Metalloproteinase Inducer from Transfected Chinese Hamster Ovary Cells J. Biol. Chem., January 3, 1997; 272(1): 24 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cao, A. Rehemtulla, W. Bahou, and S. Zucker Membrane Type Matrix Metalloproteinase 1Activates Pro-gelatinase A without Furin Cleavage of the N-terminal Domain J. Biol. Chem., November 22, 1996; 271(47): 30174 - 30180. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zucker, C. Conner, B. I. DiMassmo, H. Ende, M. Drews, M. Seiki, and W. F. Bahou Thrombin Induces the Activation of Progelatinase A in Vascular Endothelial Cells J. Biol. Chem., October 6, 1995; 270(40): 23730 - 23738. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Young, S. V. Pizzo, and M. S. Stack A Plasma Membrane-associated Component of Ovarian Adenocarcinoma Cells Enhances the Catalytic Efficiency of Matrix Metalloproteinase-2 J. Biol. Chem., January 20, 1995; 270(3): 999 - 1002. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |